Home ›
Trademark Categories ›
Pharmaceuticals ›
2020 ›
NE ›
NEXT-GEN STEROIDS
Trademark search for:
NEXT-GEN STEROIDS
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2020-03-02 — Application filed
2020-03-05 — Application filed
2020-03-08 — Application filed
2020-05-20 — Assigned to examiner
2020-05-27 — Final disposition recorded
2020-05-27 — Final disposition recorded
2020-05-27 — Final disposition recorded
2020-11-05 — Attorney/dom.rep.revoked and/or appointed
2020-11-05 — Teas change of correspondence received
2020-11-05 — Teas revoke/app/change addr of atty/dom rep received
2020-11-05 — Teas withdrawal of attorney received-firm retains
2020-11-20 — Office action issued
2020-11-20 — Correspondence received in law office
2020-11-21 — Teas/email correspondence entered
2020-11-22 — Suspension letter written
2020-11-22 — Letter of suspension e-mailed
2020-11-22 — Notification of letter of suspension e-mailed
2021-05-24 — Report completed suspension check case still suspended
2021-11-22 — Report completed suspension check case still suspended
2022-05-23 — Report completed suspension check case still suspended
2022-11-21 — Report completed suspension check case still suspended
2023-05-22 — Approved for pub - principal register
2023-06-07 — Withdrawn from pub - og review query
2023-06-07 — Notification of notice of publication e-mailed
2023-07-02 — Previous allowance count withdrawn
2023-07-05 — Final disposition recorded
2023-07-05 — Final disposition recorded
2023-07-05 — Final disposition recorded
2023-10-19 — Application abandoned
2023-10-19 — Application abandoned
2023-10-19 — Application abandoned
2023-10-19 — Final status recorded
Owner Information
Sparrow Pharmaceuticals, Inc.
Correspondent
Sean D. O'Brien MILLER NASH GRAHAM & DUNN LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
